Mechanism Investigation and Clinical Retrospective Evaluation of Qingyi Granules: Pancreas Cleaner About Ameliorating Severe Acute Pancreatitis with Acute Respiratory Distress Syndrome
DOI: https://doi.org/10.2147/dddt.s454180
IF: 4.3188
2024-06-08
Drug Design Development and Therapy
Abstract:Peng Ge, 1– 3, &ast Yalan Luo, 3, &ast Jinquan Zhang, 1– 3, &ast Jie Liu, 1– 3 Caiming Xu, 1, 4 Haoya Guo, 1– 3 Aixia Gong, 3 Guixin Zhang, 1– 3 Hailong Chen 1– 3 1 Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People's Republic of China; 2 Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, People's Republic of China; 3 Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People's Republic of China; 4 Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Biomedical Research Center, Comprehensive Cancer Center, Duarte, CA, USA &astThese authors contributed equally to this work Correspondence: Guixin Zhang; Hailong Chen, Email ; Background: Despite its extensive utilization in Chinese hospitals for treating acute pancreatitis (AP) and related acute respiratory distress syndrome (ARDS), the active components and mechanisms underlying the action of Qingyi Granule (QYKL) remain elusive. Methods: This study consists of four parts. First, we used Mendelian randomization (MR) to investigate the causal relationship between AP, cytokine, and ARDS. Next, 321 patients were collected to evaluate the efficacy of QYKL combined with dexamethasone (DEX) in treating AP. In addition, we used UHPLC-QE-MS to determine the chemical constituents of QYKL extract and rat serum after the oral administration of QYKL. The weighted gene coexpression network analysis (WGCNA) method was used to find the main targets of AP-related ARDS using the GSE151572 dataset. At last, a AP model was established by retrograde injection of 5% sodium taurocholate. Results: MR showed that AP may have a causal relationship with ARDS by mediating cytokine storms. Retrospective study results showed early administration of QYKL was associated with a lower incidence of ARDS, mortality, admissions to the intensive care unit, and length of stay in AP patients compared to the Control group. Furthermore, we identified 23 QYKL prototype components absorbed into rat serum. WGCNA and differential expression analysis identified 1558 APALI-related genes. The prototype components exhibited strong binding activity with critical targets. QYKL has a significant protective effect on pancreatic and lung injury in AP rats, and the effect is more effective after combined treatment with DEX, which may be related to the regulation of the IL-6/STAT3 signaling pathway. Conclusion: By integrating MR, retrospective analysis, and systematic pharmacological methodologies, this study systematically elucidated the therapeutic efficacy of QYKL in treating AP-related ARDS, establishing a solid foundation for its medicinal use. Keywords: acute pancreatitis, qingyi granule, dexamethasone, acute lung injury, clinical efficacy, Mendelian randomization, rat Graphical With population growth changes in the environment (including changes in dietary patterns, increasing obesity rates, smoking, and other factors), the current global incidence of AP is increasing year by year, reaching 34 patients per 100,000 population per year (95% CI: 23–49), and the mortality rate got 1.16 per 100,000 people per year (95% CI: 0. 85–1. 58). 1 A survey found that the total hospitalization expenditure for patients with AP in the United States in 2003 was as high as US 2 billion to US 1,670 per hospital day (95% confidence interval of US$1620-1720). 2 The average cost per hospitalization is nearly 10,000 US dollars, which has become a significant burden on national medical expenses. 2 Reducing hospital expenses is very important. Approximately 80% of clinical AP patients belong to mild acute pancreatitis (MAP), which could be cured by conservative treatment without any complications remaining; the other 20% of AP patients are afflicted by moderate or severe acute pancreatitis, which usually contributes to complications, including systemic inflammatory response syndrome (SIRS) and distal organ damage, such as acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). 3 Therefore, the ability to limit AP to the early stage of ARDS is of great significance to patient prognosis and the social economy. Qingyi decoction (QYD) is an optional traditional Chinese medicine prescription for the treatment of AP, which is modified by the combination of Dachengqi decoction and Dachaihu de -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal